Published Apr 16, 2026

Western Florida Compounding Pharmacy

$2.9M
Revenue
$1.1M
SDE
3.0x
Multiple
Subscribe Free

Read the full deal writeup

Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.

Get Free Access

Already a member? Sign in

Full Editorial Writeup

Highly profitable pharmacy in Western Florida doing both retail and compounding. Annual sales of $2.9 Million and filling 32,000 prescriptions per year with an estimated inventory of $90,000. Net to owner in 2025 after fully staffed was $1.13 Million.

Why we like it

  • Earnings Quality: 39% net margins on $2.9M revenue with $1.13M owner cash flow indicates exceptional profitability for a pharmacy operation. Most retail pharmacies struggle with single-digit margins due to insurance reimbursement pressures, making this margin profile a strong signal of the compounding premium.
  • Durability & Moat: Compounding pharmacies have natural competitive advantages through specialized equipment, regulatory compliance barriers, and established relationships with prescribing physicians. The dual retail/compounding model provides revenue diversification while the compounding component offers protection from big-box pharmacy competition.
  • Market Tailwinds: Aging demographics in Florida drive prescription volume growth, while increasing demand for personalized medicine and specialty compounds supports the higher-margin compounding business. Limited compounding pharmacy availability in most markets creates pricing power.
  • Operator Advantage: The business is already fully staffed and operationally mature, eliminating the typical pharmacy challenge of finding qualified pharmacists and technicians. At $91 average prescription value versus industry standard of $12-15, there's clear evidence of successful compounding integration.

How to improve it

  • Prescription Volume Growth: Implement systematic physician outreach program to expand compounding referral network, targeting pain management, dermatology, and hormone replacement specialists who frequently require custom formulations. Track new physician partnerships and prescription volume by specialty to optimize outreach efforts.
  • Inventory Optimization: Analyze the $90K inventory against fill rates and turnover metrics to identify slow-moving stock and optimize working capital. Implement just-in-time ordering for high-volume generics while maintaining safety stock for specialty compounding ingredients.
  • Service Line Expansion: Add veterinary compounding services which typically command even higher margins than human compounding and face less insurance reimbursement pressure. Many compounding pharmacies see 20-30% revenue upside from vet services with minimal additional overhead.
  • Technology Integration: Deploy pharmacy management software with automated refill reminders, prescription sync programs, and patient communication tools to improve retention and reduce staff time on administrative tasks. Modern POS systems can also provide better inventory tracking and margin analysis.
  • Insurance Optimization: Audit current insurance contracts and reimbursement rates, particularly for compounded medications where negotiations often yield better terms than standard retail prescriptions. Consider direct-pay pricing for cash customers on commonly compounded items.

Diligence notes

  • Regulatory Compliance: Verify current state pharmacy license, DEA registration, and compounding facility certifications are in good standing. Review any recent state board inspections, USP compliance status, and quality control procedures to ensure no regulatory overhang that could impact operations or require capital investment.
  • Payer Mix Analysis: Break down the $2.9M revenue by insurance types, cash pay, and compounding versus retail to understand reimbursement risk. Compounding typically has better margins but also faces more scrutiny from insurance companies, so understanding the mix is critical for forecasting.
  • Key Person Risk: Determine if the pharmacist-in-charge is the seller or an employee, and assess succession planning. Compounding requires specialized knowledge and the loss of a key pharmacist could significantly impact the higher-margin revenue stream.
  • Lease Terms: Review pharmacy lease structure, remaining term, and renewal options given the significant specialized equipment and regulatory requirements that make relocation expensive. Florida real estate has appreciated significantly, so understanding rent escalation clauses is important for margin sustainability.

Source

Originally listed on DealStream. View original listing →